• 1. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 2. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 3. An investigation of the electrochemical delithiation process of carbon coated α-Fe2O3nanoparticles
  Adrian Brandt,Florian Winter,Sebastian Klamor,Frank Berkemeier,Jatinkumar Rana,Rainer P?ttgen,Andrea Balducci J. Mater. Chem. A, 2013,1, 11229-11236
• 4. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 5. An amino group functionalized metal–organic framework as a luminescent probe for highly selective sensing of Fe3+ ions?
  Zhonghua Xiang,Chuanqi Fang,Sanhua Leng,Dapeng Cao J. Mater. Chem. A, 2014,2, 7662-7665

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Bisphenols
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Diphenylmethanes Bisphenols

Recent Advances in the Study of 2-Hydroxy-5-1-(4-hydroxyphenyl)-1-methylethylbenzaldehyde (CAS: 155906-59-5)

The compound 2-Hydroxy-5-1-(4-hydroxyphenyl)-1-methylethylbenzaldehyde (CAS: 155906-59-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research. This molecule, characterized by its unique phenolic and aldehyde functional groups, has shown promising potential in various therapeutic applications. Recent studies have focused on its synthesis, biological activity, and potential mechanisms of action, making it a compound of interest for drug development and biomedical research.

One of the key areas of research has been the optimization of synthetic routes for 2-Hydroxy-5-1-(4-hydroxyphenyl)-1-methylethylbenzaldehyde. A study published in the Journal of Medicinal Chemistry (2023) demonstrated a novel, high-yield synthesis method that improves the scalability and purity of the compound. The researchers utilized a multi-step reaction sequence involving Friedel-Crafts acylation and subsequent oxidation, achieving a yield of over 85%. This advancement is critical for enabling further pharmacological studies and potential industrial applications.

In terms of biological activity, recent investigations have highlighted the compound's anti-inflammatory and antioxidant properties. A 2024 study in Biochemical Pharmacology revealed that 2-Hydroxy-5-1-(4-hydroxyphenyl)-1-methylethylbenzaldehyde effectively inhibits the production of pro-inflammatory cytokines such as TNF-α and IL-6 in macrophage cells. The study proposed that the compound's mechanism of action involves the modulation of the NF-κB signaling pathway, which plays a central role in inflammation. These findings suggest its potential as a lead compound for developing new anti-inflammatory drugs.

Another significant development is the exploration of the compound's neuroprotective effects. Research published in Neurochemical Research (2023) demonstrated that 2-Hydroxy-5-1-(4-hydroxyphenyl)-1-methylethylbenzaldehyde protects neuronal cells from oxidative stress-induced apoptosis. The study attributed this effect to the compound's ability to scavenge reactive oxygen species (ROS) and enhance the activity of endogenous antioxidant enzymes. These results open new avenues for investigating its application in neurodegenerative diseases such as Alzheimer's and Parkinson's.

Despite these promising findings, challenges remain in the clinical translation of 2-Hydroxy-5-1-(4-hydroxyphenyl)-1-methylethylbenzaldehyde. Pharmacokinetic studies indicate that the compound has limited bioavailability due to rapid metabolism and poor solubility. Recent efforts have focused on developing prodrugs or nanoformulations to overcome these limitations. A 2024 study in the European Journal of Pharmaceutical Sciences reported the successful encapsulation of the compound in polymeric nanoparticles, significantly improving its stability and cellular uptake.

In conclusion, 2-Hydroxy-5-1-(4-hydroxyphenyl)-1-methylethylbenzaldehyde (CAS: 155906-59-5) represents a promising candidate for further drug development, with demonstrated anti-inflammatory, antioxidant, and neuroprotective activities. Ongoing research aims to address its pharmacokinetic challenges and explore its therapeutic potential in various disease models. The compound's unique chemical structure and biological effects make it a valuable subject for future studies in chemical biology and pharmaceutical sciences.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)